Cochrane Abstracts
Remacemide for drug‐resistant localization related epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Remacemide for Drug‐resistant Localization Related Epilepsy." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434228/all/Remacemide_for_drug‐resistant_localization_related_epilepsy.
Remacemide for drug‐resistant localization related epilepsy. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434228/all/Remacemide_for_drug‐resistant_localization_related_epilepsy. Accessed December 5, 2025.
Remacemide for drug‐resistant localization related epilepsy. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434228/all/Remacemide_for_drug‐resistant_localization_related_epilepsy
Remacemide for Drug‐resistant Localization Related Epilepsy [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 December 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434228/all/Remacemide_for_drug‐resistant_localization_related_epilepsy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Remacemide for drug‐resistant localization related epilepsy
ID - 434228
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434228/all/Remacemide_for_drug‐resistant_localization_related_epilepsy
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
